Therapeutic Asset Ratings
615 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DYNAMOS
Colorectal Carcinoma
Fudan University
P1/2
CC
(43)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101)
Pancreatic Ductal Adenocarcinoma
Fudan University
P1
CC
(40)
cl4
Breast Cancer
Fudan University
P1/2
CC
(40)
js007
Pancreatic Neoplasm
Fudan University
P1/2
CC
(40)
js015
Pancreatic Neoplasm
Fudan University
P1/2
CC
(40)
Shr-8068
Pancreatic Neoplasm
Fudan University
P1/2
CC
(40)
Tifcemalimab
Pancreatic Neoplasm
Fudan University
P1/2
CC
(40)
Jwcar201
Diffuse Large B-Cell Lymphoma
Fudan University
P1
C
(39)
Oxycodone
Colorectal Cancer
Fudan University
P1
C
(39)
Hrxg-K-1939
Cancer
Fudan University
P1
C
(36)
Idov-Safetm
Advanced Malignant Solid Tumor
Fudan University
Early P1
C
(36)
Bxcl501
NETs
Fudan University
N/A
D
(30)
Bxcl501
Opioid-free Anesthesia
Fudan University
N/A
D
(30)
Cetuximab
Colorectal Cancer Liver Metastases
Fudan University
N/A
D
(30)
FLURBIPROFEN
NETs
Fudan University
N/A
D
(30)
FLURBIPROFEN
Opioid-free Anesthesia
Fudan University
N/A
D
(30)
Fruquintinib
Malignant Melanoma
Fudan University
N/A
D
(30)
FULVESTRANT
Hormone-Resistant Breast Carcinoma
Fudan University
N/A
D
(30)
Leucogen
Pralsetinib
Fudan University
N/A
D
(30)
Leucogen
RET Fusion Positive Cancer
Fudan University
N/A
D
(30)
LIDOCAINE
NETs
Fudan University
N/A
D
(30)
LIDOCAINE
Opioid-free Anesthesia
Fudan University
N/A
D
(30)
Osimertinib
Stereotactic Radiation
Fudan University
D
(30)
Oxycodone
NETs
Fudan University
N/A
D
(30)
Oxycodone
Opioid-free Anesthesia
Fudan University
N/A
D
(30)
Showing 551 to 575 of 615 assets
Previous
Page 23 of 25
Next